| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -18.8% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 0.1 | n/a |
| Pr/Book | 0.5 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 13.1% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 7.61 | (1.92) | (1.83)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-08 | 15.21 | 3.98 | 3.53p | 4.2 | n/a | n/a | n/a | 0.0% |
| 31-Dec-09 | 18.71 | (1.93) | (0.10)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-10 | 21.31 | (2.04) | (1.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-11 | 24.09 | (6.60) | (3.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Interim Management Statement | 18-May-2012 | 12:30 | RNS |
| Update on Disposals | 02-May-2012 | 15:07 | RNS |
| Final Results Statement | 30-Apr-2012 | 07:00 | RNS |
| Small caps round-up: Westminster Group, Angle, A... | 30-Apr-2012 | ShareCast |
| Small caps round-up: BioSeek, 21st Century, Care... | 28-Mar-2012 | ShareCast |
| Asterand in dire straits | 31-Aug-2011 | ShareCast |
| Drug developers 'will have to carry out tests on... | 21-Mar-2006 | Times |
| Human tissue bill will outlaw research, warns dr... | 24-Feb-2004 | Guardian |
| Ex-Acambis boss joins Pharmagene | 23-Feb-2004 | Daily Mail |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.88p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 13.25p |
| 52 Week Low | 1.25p |
| Volume | 10,682 |
| Shares Issued | 118.48m |
| Market Cap | £2.22m |
| Beta | 0.22 |
| RiskGrade | 805 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
You are here: research